A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
Clinical trial NCT05352815 · COMPLETED
Trial details
- NCT number
- NCT05352815
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-03-19
- Enrollment
- 1291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.